Teknova to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Teknova (Nasdaq: TKNO), based in Hollister, California, is a key player in providing reagents for biopharmaceutical development. The company will participate in two investor conferences: the Piper Sandler 33rd Annual Healthcare Conference from November 29 to December 2, 2021, with a pre-recorded presentation on November 22 at 10:00 a.m. ET, and the Stephens 23rd Annual Investment Conference in Nashville, TN, from December 1 to 3, 2021, featuring a fireside chat on December 3 at 8:00 a.m. CT. Webcasts accessible on their Investor Relations page will remain available for 90 days.

HOLLISTER, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and molecular diagnostics, today announced that the company will participate in the following upcoming investor conferences.

Piper Sandler 33^rd Annual Healthcare Conference (Virtual)
November 29 - December 2, 2021
Teknova’s pre-recorded presentation with President and Chief Executive Officer, Stephen Gunstream, will be available online at the conference website at 10:00 a.m. ET on Monday, November 22, 2021.

Stephens 23^rd Annual Investment Conference (Nashville, TN)
December 1 - 3, 2021
Gunstream and Matt Lowell, Teknova’s Chief Financial Officer, will be participating in a fireside chat at 8:00 a.m. CT/9:00 a.m. ET on Friday, December 3, 2021.

The presentations will be webcast and may be accessed from the Investor Relations section of the Company’s website: https://ir.teknova.com/. The webcasts will be available on the Company’s website for approximately 90 days after each event.

About Teknova
Teknova is expediting clinical breakthroughs in the life sciences by providing custom products and reagents for bioprocessing, bioproduction, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high quality, custom, made-to-order products on short turnaround times and at scale across all stages of development, including commercialization. For more information about Teknova, visit www.teknova.com.

Investor Contacts
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-216-1830

Sara Michelmore
MacDougall Advisors
smichelmore@macbiocom.com
+1 781-235-3060

Media Contact
Matthew Corcoran
MacDougall Advisors
mcorcoran@macbiocom.com
+1 617-866-7350

FAQ

What upcoming conferences will Teknova participate in November 2021?

Teknova will participate in the Piper Sandler 33rd Annual Healthcare Conference from November 29 to December 2, 2021.

When is Teknova's presentation at the Piper Sandler conference?

Teknova's presentation will be available online on November 22, 2021, at 10:00 a.m. ET.

What fireside chat will Teknova hold at the Stephens conference?

Teknova will have a fireside chat on December 3, 2021, at 8:00 a.m. CT.

How can I access Teknova's conference presentations?

The presentations will be webcast and can be accessed from the Investor Relations section of Teknova's website.

What is Teknova known for in the biopharmaceutical industry?

Teknova is known for providing critical reagents for drug therapies, vaccines, and molecular diagnostics.